Demonstration Formulary
1 Gastro-intestinal system
fgsdfgsdfgs
01-02 Antispasmodics and other drugs altering gut motility
| Hyoscine Butylbromide |
|
Formulary
|
10mg Tablet 20mg/ml Injection |
 NICE CG61: Irritable bowel syndrome in adults: diagnosis and management |
|
| Metoclopramide |
|
Formulary
|
Nausea and vomiting
|
|
MHRA: Metoclopramide: risk of neurological adverse effects (Published 11 December 2014) |
|
|
| Eluxadoline |
|
Non Formulary
|
In line with NICE Specialist initiation, transfer of prescribing supported by a RICaD |
|
NICE TA471: Eluxadoline for treating irritable bowel syndrome with diarrhoea |
|
Links
- MHRA: Domperidone: risk of cardiac side effects (Published 11 December 2014)
- MHRA: Metoclopramide: risk of neurological adverse effects (Published 11 December 2014)
- NICE CG49: Faecal incontinence in adults: management
- NICE CG61 : Irritable bowel syndrome in adults: diagnosis and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE CG99: Constipation in children and young people: diagnosis and management
- NICE TA471: Eluxadoline for treating irritable bowel syndrome with diarrhoea
- NICE: Promoting tolerance of enteral feeds in children and young people: domperidone